Stromal expression of matrix metalloproteinase 2 in cancer-associated fibroblasts is strongly related to human epidermal growth factor receptor 2 status in invasive breast carcinoma

Catteau,Xavier; Simon,Philippe; Noël,Jean‑Christophe

doi:10.3892/mco.2015.721

Stromal expression of matrix metalloproteinase 2 in cancer-associated fibroblasts is strongly related to human epidermal growth factor receptor 2 status in invasive breast carcinoma

Authors:
- Xavier Catteau
- Philippe Simon
- Jean‑Christophe Noël
View Affiliations

Affiliations: Institute of Pathology and Genetics, B-6041 Gosselies, Belgium, Faculty of Medicine, Université Libre de Bruxelles, B-1070 Brussels, Belgium
Published online on: December 24, 2015 https://doi.org/10.3892/mco.2015.721
Pages: 375-378

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The peritumoral stroma and cancer-associated fibroblasts (CAFs) have been suggested to play an important role in breast tumorigenesis. The specific immunohistochemical characteristics of the stromal component according to the breast carcinoma subtype surrogates of molecular classes is poorly understood. In the present study, immunohistochemical staining was used to evaluate the expression of matrix metalloproteinase 2 (MMP2), which is one of the most important proteins considered to facilitate tumor invasion, in a series of invasive breast carcinomas according to subtype: luminal A, luminal B, luminal‑HER2, HER2‑enriched and triple‑negative. a significant increase in MMP2 expression was demonstrated in tumors known to exhibit a more aggressive metastatic behavior, such as luminal HER2 (37%), HER2‑enriched (30%) and triple‑negative tumors (17%), compared with the luminal A (6%) or luminal B (13%) subtypes. Our data indicated that the CAFs associated with different breast subtypes exhibit different specific properties to facilitate tumor invasion.

View Figures

View References

1	Luo H, Tu G, Liu Z and Liu M: Cancer-associated fibroblasts: A multifaceted driver of breast cancer progression. Cancer Lett. 361:155–163. 2015. View Article : Google Scholar : PubMed/NCBI
2	Han Y, Zhang Y, Jia T and Sun Y: Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts. Tumour Biol. 36:1385–1394. 2015. View Article : Google Scholar : PubMed/NCBI
3	Catteau X, Simon P and Noël JC: Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: Possible role of the TGF-β1/TGF-βR1 pathway. BMC Cancer. 14:4992014. View Article : Google Scholar : PubMed/NCBI
4	Catteau X, Simon P and Noël JC: Myofibroblastic reaction is a common event in metastatic disease of breast carcinoma: A descriptive study. Diagn Pathol. 9:1962014. View Article : Google Scholar : PubMed/NCBI
5	Kohlhapp FJ, Mitra AK, Lengyel E and Peter ME: MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene April. 13:2015.(Epub ahead of print).
6	Hassona Y, Cirillo N, Heesom K, Parkinson EK and Prime SS: Senescent cancer-associated fibroblasts secrete active MMP-2 that promotes keratinocyte dis-cohesion and invasion. Br J Cancer. 111:1230–1237. 2014. View Article : Google Scholar : PubMed/NCBI
7	Jezierska A and Motyl T: Matrix metalloproteinase-2 involvement in breast cancer progression: A mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
8	Lakhani SR, Ellis IO, Schnitt SJ, Tan PH and van de Vijver MJ: Invasive breast carcinoma: Introduction and general features. WHO Classification of Tumours. 4:(4th). (Lyon). IARC Press. 19–22. 2012.
9	Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
10	Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, et al: Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 31:3997–4013. 2013. View Article : Google Scholar : PubMed/NCBI
11	Preat F, Simon P and Noel JC: Differences in breast carcinoma immunohistochemical subtypes between immigrant Arab and European women. Diagn Pathol. 9:262014. View Article : Google Scholar : PubMed/NCBI
12	Sihto H, Lundin J, Lundin M, Lehtimäki T, Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T, Isola J, et al: Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: A nationwide cohort study. Breast Cancer Res. 13:R872011. View Article : Google Scholar : PubMed/NCBI
13	Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277. 2010. View Article : Google Scholar : PubMed/NCBI
14	De Wever O, Demetter P, Mareel M and Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 123:2229–2238. 2008. View Article : Google Scholar : PubMed/NCBI
15	Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Hallett M and Park M: Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 14:518–527. 2008. View Article : Google Scholar : PubMed/NCBI
16	Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, Becette V, André S, Piccart M, Campone M, Brain E, et al: A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med. 15:68–74. 2009. View Article : Google Scholar : PubMed/NCBI
17	Gupta GP and Massagué J: Cancer metastasis: Building a framework. Cell. 127:679–695. 2006. View Article : Google Scholar : PubMed/NCBI
18	Duffy MJ, Maguire TM, Hill A, McDermott E and O'Higgins N: Metalloproteinases: Role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2:252–257. 2000. View Article : Google Scholar : PubMed/NCBI
19	Jones JL, Glynn P and Walker RA: Expression of MMP-2 and MMP-9, their inhibitors and the activator MT1-MMP in primary breast carcinomas. J Pathol. 189:161–168. 1999. View Article : Google Scholar : PubMed/NCBI
20	Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R and Wapnir I: Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat. 31:357–370. 1994. View Article : Google Scholar : PubMed/NCBI